Showing results (91-100 of 106) with videos related to
Sort By:
Pageof 11
Molecular Cell|December 8, 2023
SRSF2 plays an unexpected role as reader of m5C on mRNA, linking epitranscriptomics to cancerHai-Li Ma, Martin Bizet, Christelle Soares Da Costa, et al.Nature Communications|February 25, 2016
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agentsJane Merlevede, Nathalie Droin, Tingting Qin, et al.Cancer Discovery|August 27, 2024
RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal HematopoiesisNana Adjoa Ben-Crentsil, Wazim Mohammed Ismail, Maria E Balasis, et al.Cancer Discovery|April 26, 2019
A Recurrent Activating Missense Mutation in Waldenström Macroglobulinemia Affects the DNA Binding of the ETS Transcription Factor SPI1 and Enhances ProliferationDamien Roos-Weil, Camille Decaudin, Marine Armand, et al.Cancer Discovery|October 31, 2019
Ontogenic Changes in Hematopoietic Hierarchy Determine Pediatric Specificity and Disease Phenotype in Fusion Oncogene-Driven Myeloid LeukemiaCécile K Lopez, Esteve Noguera, Vaia Stavropoulou, et al.Cancer Discovery|October 3, 2018
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell LymphomagenesisPilar M Dominguez, Hussein Ghamlouch, Wojciech Rosikiewicz, et al.Nature Communications|May 19, 2021
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axisRyan M Carr, Denis Vorobyev, Terra Lasho, et al.Science Translational Medicine|July 12, 2019
A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndromeSabrina Bondu, Anne-Sophie Alary, Carine Lefèvre, et al.Nature Communications|April 8, 2024
Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutationDavid Rombaut, Carine Lefèvre, Tony Rached, et al.Cancer Discovery|January 20, 2023
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural MesotheliomaFrançois-Xavier Danlos, Matthieu Texier, Bastien Job, et al.Pageof 11